20/20 Biolabs (AIDX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
20/20 Biolabs, Inc.  (Nasdaq: AIDX)
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology

20/20 Biolabs Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AIDX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 41.71 % 46.51 % 57.69 % 46.05 %
Gross Margin (Q2 TTM) 32.07 % 46.11 % 57.24 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 45.13 % 46.12 % 27.29 %
EBITDA Margin (Q2 MRQ) 40.38 % 24.94 % 39.07 % 20.6 %
EBITDA Margin (Q2 TTM) 27.52 % 22.36 % 34.64 % 19.1 %
EBITDA Margin 5 Yr. Avg. - 5.82 % 21.49 % 10.71 %
Operating Margin (Q2 MRQ) -170.31 % 19.47 % 28.71 % 16.03 %
Operating Margin (Q2 TTM) -198.15 % 17.56 % 27.15 % 16.33 %
Operating Margin 5 Yr. Avg. - --6.77 % 15.66 % 8.17 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 18.04 % 33.67 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) 0 % 15.94 % 29.16 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - - 16.42 % 8.22 %
Net Margin (Q2 MRQ) -360.13 % 15.78 % 29.04 % 11.41 %
Net Margin (Q2 TTM) -295.07 % 13.04 % 24.32 % 10.75 %
Net Margin 5 Yr. Avg. - - 13.75 % 6.23 %



Business Segment Profit Margin
 
CLI Ax
  Explore CLI Ax Segment  -
One Test
  Explore One Test Segment  -
Bio Check
  Explore Bio Check Segment  -